Tourmaline Bio

Tourmaline Bio is a late-stage clinical biotechnology company dedicated to developing transformative medicines that significantly improve the lives of patients suffering from life-altering immune and inflammatory diseases. Their primary focus is on developing therapies for autoimmune and cardiovascular inflammatory conditions. Tourmaline's lead product candidate, pacibekitug, is a long-acting, fully human monoclonal antibody with best-in-class potential. This investigational drug targets interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory diseases.

Tourmaline Bio is currently running two clinical trials evaluating pacibekitug. The spiriTED study is a Phase 2b trial evaluating the drug for the treatment of thyroid eye disease (TED). The TRANQUILITY trial is a Phase 2 study evaluating pacibekitug for the treatment of atherosclerotic cardiovascular disease (ASCVD). The company is also pursuing additional opportunities for pacibekitug in other areas where IL-6 inhibition has shown clinical benefit, including inflammatory bowel disease, rheumatoid arthritis, and lupus.

Tourmaline Bio offers a hybrid work model for many of its roles, allowing employees to work remotely with the option of working from their New York office when necessary. The company also provides a variety of flexible work arrangements, as evidenced by the numerous job postings indicating a remote or hybrid work setup, although the exact flexibility for each position may vary.

Tourmaline Bio provides a robust benefits package that includes comprehensive medical, dental, and vision insurance, a 401(k) plan with employer matching, and paid time off, including vacation, sick leave, and holidays. The company also offers a professional development program and a variety of employee resource groups to support their diverse workforce.

Tourmaline Bio is a clinical-stage biotechnology company dedicated to developing transformative medicines that dramatically improve the lives of patients with life-altering immune and inflammatory diseases. They are particularly focused on developing medicines that can establish new standards of care in areas of high unmet medical need, driven by their passion for improving patient outcomes and their commitment to a nimble, driven, and accomplished team of experts.

Tourmaline Bio promotes a culture centered on respect, inclusivity, and a passion for achieving results for patients. The company encourages an "all hands on deck" mentality, valuing diverse perspectives and collaboration. They prioritize challenging the status quo, taking calculated risks, and fostering a culture of continuous learning and improvement.

Tourmaline Bio is committed to fostering a diverse, equitable, and inclusive workplace. The company believes that respect and inclusion are core to its success, emphasizing the value of diverse experiences and perspectives. They strive to operate in a respectful, transparent, and honest way, collaborating with kindness and focusing on the problem rather than individuals or groups. Tourmaline actively incorporates diversity, equity, and inclusion initiatives into its hiring, development, and culture-building efforts.